Profiel
Bert Barbosa currently works at Ajinomoto Bio-Pharma Services, as President & Chief Operating Officer from 2023 and Ajinomoto Althea, Inc., as President & Chief Operating Officer.
Actieve functies van Bert Barbosa
| Bedrijven | Functie | Begin |
|---|---|---|
Ajinomoto Bio-Pharma Services
 Ajinomoto Bio-Pharma Services BiotechnologyHealth Technology Ajinomoto Bio-Pharma Services provides clinical and commercial product development, manufacturing and fill finish services. It offers platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing. The company was founded in 2018 and is headquartered in San Diego, CA. | President | 01-05-2018 |
Ajinomoto Althea, Inc.
 Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Health Technology |
Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services BiotechnologyHealth Technology Ajinomoto Bio-Pharma Services provides clinical and commercial product development, manufacturing and fill finish services. It offers platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing. The company was founded in 2018 and is headquartered in San Diego, CA. | Health Technology |
